SVB Wealth’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,981
Closed -$300K 1727
2024
Q4
$300K Buy
+18,981
New +$285K 0.01% 556
2024
Q3
Sell
-18,845
Closed -$287K 466
2024
Q2
$287K Sell
18,845
-620
-3% -$8.89K 0.01% 575
2024
Q1
$286K Sell
19,465
-7,995
-29% -$117K 0.01% 650
2023
Q4
$382K Buy
27,460
+65
+0.2% +$869 0.01% 557
2023
Q3
$366K Buy
27,395
+180
+0.7% +$2.44K 0.01% 543
2023
Q2
$344K Buy
27,215
+640
+2% +$7.47K 0.01% 612
2023
Q1
$303K Buy
26,575
+5,685
+27% +$61.4K ﹤0.01% 719
2022
Q4
$216K Buy
20,890
+25
+0.1% +$270 ﹤0.01% 885
2022
Q3
$218K Buy
+20,865
New +$222K ﹤0.01% 822
2022
Q2
Sell
-20,455
Closed -$228K 827
2022
Q1
$228K Sell
20,455
-2,720
-12% -$30.8K ﹤0.01% 662
2021
Q4
$303K Sell
23,175
-1,540
-6% -$19.4K 0.01% 575
2021
Q3
$322K Buy
24,715
+3,530
+17% +$47K ﹤0.01% 758
2021
Q2
$312K Buy
21,185
+570
+3% +$7.97K ﹤0.01% 742
2021
Q1
$253K Buy
20,615
+830
+4% +$10.7K ﹤0.01% 760
2020
Q4
$282K Buy
19,785
+2,540
+15% +$34.2K ﹤0.01% 643
2020
Q3
$240K Buy
+17,245
New +$206K ﹤0.01% 579

Other funds holding RDY

SVB Wealth's RDY Position: Q1 2025 in Review

SVB Wealth sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 18,981 shares — an estimated $300K sold.

SVB Wealth first reported a position in RDY in Q3 2020 and held it in 16 quarters. The position peaked at $382K in Q4 2023. 246 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • SVB Wealth reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
  • SVB Wealth sold 18,981 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $300K.
  • SVB Wealth first reported a position in Dr. Reddy's Laboratories in Q3 2020 and held it in 16 quarters.
  • SVB Wealth's Dr. Reddy's Laboratories position peaked at $382K in Q4 2023.
  • 246 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on SVB Wealth's 13F filing for Q1 2025, filed 14 May 2025.